The therapeutic target of estrogen receptor-alpha36 in estrogen-dependent tumors.

The therapeutic target of estrogen receptor-alpha36 in estrogen-dependent tumors.
复制标题

雌激素受体-α36在雌激素依赖性肿瘤中的治疗靶点

DOI:
10.1186/1479-5876-12-16
复制
发表时间:
2014-01-21
影响因子:
7.4
通讯作者:
Teng L
Teng L
中科院分区:
医学2区
文献类型:
--
作者:
Gu Y;Chen T;López E;Wu W;Wang X;Cao J;Teng L

文献摘要

参考文献

被引文献

相似文献

雌激素受体-α 36(ER-α36)是一种新的雌激素受体亚型,不含经典ER-α(ER-α66)的转录激活结构域。ER-α36主要定位于细胞质和质膜。ER-α36介导非基因组信号传导,并参与其他ER的基因组信号传导。近年来发现ER-α36在雌激素依赖性肿瘤的发生和乳腺癌的内分泌抵抗中起着重要作用。本文就ER-α36的生物学性质和功能、ER-α36与其他雌激素受体和生长因子受体的相互作用、细胞内信号传导途径、ER-α36在肿瘤内分泌治疗耐药中的作用机制等方面进行综述。
Estrogen receptor-alpha36 (ER-α36) is a new isoform of estrogen receptors without transcriptional activation domains of the classical ER-α(ER − α66). ER-α36 is mainly located in cytoplasm and plasma membrane. ER-α36 mediates non-genomic signaling and is involved in genomic signaling of other ERs. Recently ER-α36 is found to play a critical role in the development of estrogen-dependent cancers and endocrine resistance of breast cancer. The present article overviews and updates the biological nature and function of ER-α36, potential interaction of ER-α36 with other estrogen receptors and growth factor receptors, intracellular signaling pathways, potential mechanism by which ER-α36 may play an important role in the development of tumor resistance to endocrine therapies.
DOI: 10.1200/jco.2002.20.3.751
发表时间: 2002-02-01
影响因子: 45.3
作者:
Geisler, J;Haynes, B;Lonning, PE
通讯作者: Lonning, PE
DOI: 10.1210/en.140.12.5566
发表时间: 1999-12-01
期刊: ENDOCRINOLOGY
影响因子: 4.8
作者:
Hall, JM;McDonnell, DP
通讯作者: McDonnell, DP
DOI: 10.1073/pnas.91.18.8517
发表时间: 1994-08-30
影响因子: 11.1
作者:
ARONICA, SM;KRAUS, WL;KATZENELLENBOGEN, BS
通讯作者: KATZENELLENBOGEN, BS
DOI: 10.1091/mbc.e04-07-0547
发表时间: 2005-01-01
影响因子: 3.3
作者:
Acconcia, F;Ascenzi, P;Marino, M
通讯作者: Marino, M
DOI: 10.3892/or_00000842
发表时间: 2010-07-01
期刊: ONCOLOGY REPORTS
影响因子: 4.2
作者:
Deng, Hao;Huang, Xuan;Liu, Lijiang
通讯作者: Liu, Lijiang